Contrast Media

The American Society of Echocardiography Foundation (ASEF) launched the second version of its free mobile Echo AUC app at the ASE Silver Anniversary Scientific Sessions in Portland, Ore., last week.

Bayer HealthCare announced the U.S. Food and Drug Administration (FDA) approved a new indication for Gadavist (gadobutrol) injection for intravenous use with magnetic resonance imaging (MRI) of the breast to assess the presence and extent of...

April 18, 2014 — Guerbet announced that Lipiodol was approved by the U.S. Food and Drug Administration (FDA), indicated for selective hepatic intra-arterial use for imaging tumors in adults with known hepatocellular carcinoma (HCC).

GE Healthcare announced results from a new clinical study, which showed that patients receiving iodixanol (Visipaque) 320mg I/ml reported less discomfort, characterized by heat or cold sensation or pain upon injection, than patients receiving iopa...

Nephrocheck Test System, Blood testing, contrast media
Ortho-Clinical Diagnostics Inc. announced the nationwide availability to hospitals of the Nephrocheck Test System designed to help healthcare providers...
Bayer Healthcare, Gadavist, FDA, approval, pediatric patients, contrast media
Bayer HealthCare announced that the U.S. Food and Drug Administration (FDA) has approved Gadavist (gadobutrol) injection for use with magnetic resonance...
Data from a Bayer study in children less than 2 years of age (infants) was presented at the 2014 Radiological Society of North America (RSNA)...
Bracco Diagnostics Inc. announced the availability of its Isovue (iopamidol injection) Imaging Bulk Package (IBP), a specific combination multi-patient, multi-...
Bayer Healthcare, Gadavist, FDA, approval, pediatric patients, contrast media
The U.S. Food and Drug Administration (FDA) approved Gadavist (gadobutrol) injection for use with magnetic resonance imaging (MRI) in
Version 2.5 of Bayer's Radimetrics Enterprise Platform has new features that can help radiologists and hospital administrators meet new...
The Isovue (iopamidol injection) Imaging Bulk Package (IBP) from Bracco Imaging Inc. is a specific combination multi-patient, multi-dose...
Lumason (sulfur hexafluoride lipid microsphere) is a contrast agent for patients whose ultrasound image of the heart (echocardiograms) are...

Articles

Bayer Healthcare, Gadavist, FDA, approval, pediatric patients, contrast media
Bayer HealthCare announced that the U.S. Food and Drug Administration (FDA) has approved Gadavist (gadobutrol) injection for use with magnetic resonance...
Data from a Bayer study in children less than 2 years of age (infants) was presented at the 2014 Radiological Society of North America (RSNA)...
The use of contrast media in many imaging modalities continues to evolve as physicians seek to improve dose management practices and vendors churn out...
September 10, 2014 — According to new research performed at the Mayo Clinic, iodine-based contrast material injected intravenously to enhance computed...

Video Center

The silence is deafening. And since radiology associations, physician groups and vendors have yet...
1 day 6 hours ago
There were a few intriguing technology trends at the Radiological Society of North America (RSNA)...
6 weeks 3 hours ago
All major technology advances in the world of radiology and imaging are unveiled or highlighted at...
12 weeks 2 days ago
The webinar "State of the Art in MRI Pediatric Brain Perfusion Imaging" educates participants about the state of the art clinical and emerging translational...
This webinar discusses why contemporary adult cardiac interventions require significant ionizing radiation with potential health risks to both the patient and...
The webinar "Any Image, Anywhere" explains the new ways radiologists and clinicians can boost productivity, optimize scarce resources, and connect their...

Comparison Charts